ZeinaAl-MansourMD
Hematology • Gainesville, FLHematologic Oncology
Associate Professor of Medicine Malignant Hematology, Transplant & Cellular Therapy University of Florida - Shands Cancer Hospital
Dr. Al-Mansour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-733-0972
Summary
- Dr. Zeina Al-Mansour is a hematologist specializing in BMT & Cellular Therapy in Gainesville, FL and is affiliated with UF Health Shands Hospital. She received her medical degree from Jordan University of Science and Technology (Irbid, Jordan), completed her Internship in IM in University of New Mexico (Albuquerque, NM), completed her IM Residency & Hematology/Oncology Fellowship Training in University of Massachusetts Medical Center (Worcester, MA). She is board certified in IM, Hematology and Medical Oncology and has been practicing malignant hematology, BMT/Cellular Therapy in academic institutions for the past 9 years. Her area of interest is myeloid malignancies and cellular therapies in elderly population, focusing on optimization of disease control pre-transplant and rehabilitation as the basis to improve transplant outcomes in elderly.
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2012 - 2015- UMass Chan Medical SchoolResidency, Internal Medicine, 2010 - 2012
University of New Mexico School of MedicineInternship, Internal Medicine, 2009 - 2010
Jordan University of Science and Technology FOMClass of 2006
Certifications & Licensure
FL State Medical License 2020 - 2026
IL State Medical License 2015 - 2020
MA State Medical License 2017 - 2020
NM State Medical License 2008 - 2010- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage Start of enrollment: 2019 Nov 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 56 citationsDiffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.Luciano J. Costa, Kami J. Maddocks, Narendranath Epperla, Nishitha Reddy, Reem Karmali
American Journal of Hematology. 2017-02-01 - 9 citationsGut Microbiota Dysbiosis Associated with Persistent Fatigue in Hematopoietic Cell Transplantation Survivors.Nosha Farhadfar, Raad Z. Gharaibeh, Wendy J. Dahl, Lacey Mead, Karima Alabasi
Transplantation and Cellular Therapy. 2021-06-01 - 9 citationsBaseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation.Hemant S. Murthy, Raad Z. Gharaibeh, Zeina Al-Mansour, Andrew Kozlov, Gaurav Trikha
Biology of Blood and Marrow Transplantation. 2020-11-01
Professional Memberships
- Member
- Member
- American Society for Transplant & Cellular Therapy (ASTCT)Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
